Quote:
Originally Posted by Patton250
|
Pls check your "facts" again.
That Kennedy dude has no validity at all.
"For most immunities, vaccines not only are safer but produce a more robust response. This includes vaccines for HPV, tetanus, and pneumonia; mumps is an exception. "
https://www.acsh.org/news/2021/03/19...n-better-15409
"Benefit of Vaccines:
Varicella (chickenpox) vaccine was licensed in 1995. Since 1996, the number of hospitalizations and deaths from varicella has declined more than 90%.
1 dose of varicella is 85% effective in preventing any form of chickenpox and almost 100% effective against severe chickenpox.
In pre-licensure studies: 2 doses of varicella are 98% effective at preventing any form of varicella and 100% effective against severe chickenpox.
In post-licensure studies: 2 doses of varicella vaccine are 88-98% effective at preventing all chickenpox.
Human papillomavirus (HPV) vaccine – The high purity of the specific protein in the
vaccine leads to a better immune response than natural infection.
Tetanus vaccine – The toxin made by tetanus is so potent that the amount that causes
disease is actually lower than the amount that induces a long-lasting immune response.
This is why people with tetanus disease are still recommended to get the vaccine.
Haemophilus influenzae type b (Hib) vaccine – children less than 2 years old do not
typically make a good response to the complex sugar coating (polysaccharide) on the
surface of Hib that causes disease; however, the vaccine links this polysaccharide to a
helper protein that creates a better immune response than would occur naturally.
Therefore, children less than 2 years old who get Hib disease are still recommended to
get the vaccine.
Pneumococcal vaccine – This vaccine works the same way as the Hib vaccine to create a
better immune response than natural infection."
https://www.michigan.gov/documents/m...y_479884_7.pdf
"By closely examining the results, the researchers uncovered important differences between acquired immunity in people who’d been vaccinated and unvaccinated people who’d been previously infected with SARS-CoV-2. Specifically, antibodies elicited by the mRNA vaccine were more focused to the RBD compared to antibodies elicited by an infection, which more often targeted other portions of the spike protein. Importantly, the vaccine-elicited antibodies targeted a broader range of places on the RBD than those elicited by natural infection.
"These findings suggest that natural immunity and vaccine-generated immunity to SARS-CoV-2 will differ in how they recognize new viral variants. What’s more, antibodies acquired with the help of a vaccine may be more likely to target new SARS-CoV-2 variants potently, even when the variants carry new mutations in the RBD."
"A third difference is that natural infection only exposes the body to the virus in the respiratory tract (unless the illness is very severe), while the vaccine is delivered to muscle, where the immune system may have an even better chance of seeing it and responding vigorously."
https://directorsblog.nih.gov/2021/0...-an-infection/